FIELD: biotechnology.
SUBSTANCE: use of antisense oligonucleotide 5'-AGCTATCTCCG-3' from mouse melanoma glucose-6-phosphate dehydrogenase gene as an antitumor compound acting on the enzyme of the pentose phosphate pathway glucose-6-phosphate dehydrogenase in the treatment of melanoma is proposed.
EFFECT: invention provides reduction of tumor size in animals.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT INDUCING CELL DEATH FOR CELLS HAVING BRAF GENE MUTATIONS, AGENT SUPPRESSING GROWTH OF SUCH CELLS, AND PHARMACEUTICAL COMPOSITION FOR THE THERAPY OF DISEASES CAUSED BY GROWTH DEFECT OF SUCH CELLS | 2016 |
|
RU2760835C2 |
| APILIMOD COMPOSITION AND METHODS OF USING IT IN TREATING MELANOMA | 2015 |
|
RU2731908C2 |
| OLIGOMER COMPOUND REDUCING EXPRESSION OF HUMAN GENE Bcl-2, CONJUGATE, PHARMACEUTICAL COMPOSITION AND APPLICATION OF OLIGOMER COMPOUND IN CANCER TREATMENT | 2004 |
|
RU2377301C2 |
| MULTI-PURPOSE PROMOTER, EXPRESSION VECTOR, AND METHOD OF SELECTIVE KILLING CANCER CELLS WITH THEIR USE | 2012 |
|
RU2476596C1 |
| COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING CANCER | 2011 |
|
RU2595389C2 |
| METHOD FOR IDENTIFYING COMPOUNDS FOR TREATING CANCER | 2010 |
|
RU2575828C2 |
| BRAF KINASE INHIBITOR N-(3-(5-(4-CHLOROPHENYL)-1H-PYRAZOLO[3,4-B]PYRIDIN-3-CARBONIL)-2,4-DIFLUOROPHENYL)PROPANE-1-SULFONAMIDE | 2018 |
|
RU2687107C1 |
| COMPOUND FOR TREATING CANCER | 2014 |
|
RU2708247C2 |
| N-(3-(5-(4-CHLOROPHENYL)-1N-PYRAZOLO[3,4-B]PYRIDINE-3-CARBONYL)-2,4-DIFLUOROPHENYL)PROPANE-1-SULPHONAMIDE CRYSTALLINE FORM, ACTIVE COMPONENT, PHARMACEUTICAL COMPOSITION AND MEDICINE | 2018 |
|
RU2678455C1 |
| USE OF ALPHAVIRUS IN PREPARATION OF ANTITUMOR DRUGS | 2015 |
|
RU2693938C2 |
